Nanotechnology

[shmoopy38]

SOTK had already guided weaker sales for Q1 from their electronics business which has been de-emphasized due to overseas competition. This is what has led to a big transformation of the company and a major diversification program.

What I liked in the 10-Q was:

-the higher sales of stent coating equipment which should start to accelerate now that all of the big medical device makers are introducing next-generation drug coated stents;

-higher WideTrack equipment sales which are being applied to coatings for glass, textiles, plastic, metal, food products and packaging materials;

-and the uptick in the gross profit margin to 49% from 46.5%.

http://biz.yahoo.com/e/070622/sotk.ob10qsb.html